N Concordance 1 f (neo-)adjuvant combined treatment for rectal cancer in an attempt to evaluate 2 ho had undergone anterior resection for rectal cancer with straight colorectal r 3 therapy. Patients with stage II or III rectal cancer are at high risk for local 4 y: local recurrence is a major event in rectal cancer whereas metastases are the 5 e and scheduling, although it includes rectal cancer and stage II colon cancer 6 rocedures are now commonly used for low rectal cancer but straight colo-anal ana 7 surgery. Without radiation, the risk of rectal cancer recurrence is close to fif 8 ion and intersphincteric extirpation of rectal cancer in the distal third of the 9 s with initially non-resectable primary rectal cancer were reviewed. METHODS: Th 10 therapy in patients with poor-prognosis rectal cancer worth the decrease in qua 11 ll mortality of patients with recurrent rectal cancer is limited by the relativ 12 ts with locally advanced non-resectable rectal cancer were treated with pre-oper 13 iverting colostomy, but 7 patients with rectal cancer suffered from neurogenic b